Stent Thrombosis

Current Management and Outcomes

Per Sommer, Ehrin J. Armstrong

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Stent thrombosis (ST) is an uncommon but highly morbid complication of percutaneous coronary interventions. The mechanisms leading to ST are heterogeneous, likely accounting for the variable timing and outcomes of ST. For the clinician, it is important to recognize major risk factors for ST, including discontinuation of dual antiplatelet therapy. Once ST occurs, management includes intensive antithrombotic and antiplatelet therapies. Newer antiplatelet agents may reduce the risk of ST and possibly minimize adverse outcomes after presentation with ST.

Original languageEnglish (US)
JournalCurrent Treatment Options in Cardiovascular Medicine
Volume17
Issue number3
DOIs
StatePublished - 2015
Externally publishedYes

Fingerprint

Stents
Thrombosis
Platelet Aggregation Inhibitors
Percutaneous Coronary Intervention
Therapeutics

Keywords

  • Bare metal stent
  • Drug-eluting stent
  • Early stent thrombosis
  • Intraprocedural stent thrombosis
  • Late stent thrombosis
  • Recurrent stent thrombosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Stent Thrombosis : Current Management and Outcomes. / Sommer, Per; Armstrong, Ehrin J.

In: Current Treatment Options in Cardiovascular Medicine, Vol. 17, No. 3, 2015.

Research output: Contribution to journalArticle

@article{98d981e9e724469889b6bb97d473d234,
title = "Stent Thrombosis: Current Management and Outcomes",
abstract = "Stent thrombosis (ST) is an uncommon but highly morbid complication of percutaneous coronary interventions. The mechanisms leading to ST are heterogeneous, likely accounting for the variable timing and outcomes of ST. For the clinician, it is important to recognize major risk factors for ST, including discontinuation of dual antiplatelet therapy. Once ST occurs, management includes intensive antithrombotic and antiplatelet therapies. Newer antiplatelet agents may reduce the risk of ST and possibly minimize adverse outcomes after presentation with ST.",
keywords = "Bare metal stent, Drug-eluting stent, Early stent thrombosis, Intraprocedural stent thrombosis, Late stent thrombosis, Recurrent stent thrombosis",
author = "Per Sommer and Armstrong, {Ehrin J.}",
year = "2015",
doi = "10.1007/s11936-015-0365-2",
language = "English (US)",
volume = "17",
journal = "Current Treatment Options in Cardiovascular Medicine",
issn = "1092-8464",
publisher = "Current Science, Inc.",
number = "3",

}

TY - JOUR

T1 - Stent Thrombosis

T2 - Current Management and Outcomes

AU - Sommer, Per

AU - Armstrong, Ehrin J.

PY - 2015

Y1 - 2015

N2 - Stent thrombosis (ST) is an uncommon but highly morbid complication of percutaneous coronary interventions. The mechanisms leading to ST are heterogeneous, likely accounting for the variable timing and outcomes of ST. For the clinician, it is important to recognize major risk factors for ST, including discontinuation of dual antiplatelet therapy. Once ST occurs, management includes intensive antithrombotic and antiplatelet therapies. Newer antiplatelet agents may reduce the risk of ST and possibly minimize adverse outcomes after presentation with ST.

AB - Stent thrombosis (ST) is an uncommon but highly morbid complication of percutaneous coronary interventions. The mechanisms leading to ST are heterogeneous, likely accounting for the variable timing and outcomes of ST. For the clinician, it is important to recognize major risk factors for ST, including discontinuation of dual antiplatelet therapy. Once ST occurs, management includes intensive antithrombotic and antiplatelet therapies. Newer antiplatelet agents may reduce the risk of ST and possibly minimize adverse outcomes after presentation with ST.

KW - Bare metal stent

KW - Drug-eluting stent

KW - Early stent thrombosis

KW - Intraprocedural stent thrombosis

KW - Late stent thrombosis

KW - Recurrent stent thrombosis

UR - http://www.scopus.com/inward/record.url?scp=84923677476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923677476&partnerID=8YFLogxK

U2 - 10.1007/s11936-015-0365-2

DO - 10.1007/s11936-015-0365-2

M3 - Article

VL - 17

JO - Current Treatment Options in Cardiovascular Medicine

JF - Current Treatment Options in Cardiovascular Medicine

SN - 1092-8464

IS - 3

ER -